Skip to main content
. 2021 Sep 2;2021(9):CD013825. doi: 10.1002/14651858.CD013825.pub2

6.15. Analysis.

6.15

Comparison 6: Bamlanivimab in hospitalised individuals with COVID‐19 (moderate and severe disease), Outcome 15: Renal dysfunction (or need for dialysis) by day 30